Establishing Novel Biomarkers to Track Multiple Sclerosis

Dr. Abdelhak is working to create a sensitive blood-based test to measure ongoing damage to myelin, the insulating layer that forms around nerve cells to allow electrical impulses to transmit efficiently. Damage and loss of myelin is the pathological hallmark in demyelinating diseases like multiple sclerosis, though the ability to actively measure myelin damage is still a significant unmet need in clinical neurology.